The Latest Breaking News from diabetes

Cayla George believes her coach's brutal words of wisdom are important while Lara McSpadden and Lauren Cox aim to inspire the next generation of diabetics.

Persistent wounds can signal slow wound healing from nutrient deficiencies or diabetes symptoms; learn key causes, lab markers, and treatment approaches.

Researchers say new compound improves metabolic activity within muscles instead of acting on hunger pathways like Ozempic and Wegovy

The U.S. Food and Drug Administration (FDA) in December issued a safety alert urging people with diabetes to stop using select glucose sensors made by Abbott Laboratories’ (NYSE:ABT) Diabetes Care, after the company linked the devices to seven deaths and hundreds of serious injuries.

Imagine trying to enjoy your favourite meal but finding that your gums hurt, your mouth feels dry and chewing has become uncomfortable. For people living with diabetes, this can be a daily reality that often goes unrecognised.

The rise of GLP-1 drugs such as Ozempic and Mounjaro has been nothing short of meteoric. Originally developed to treat diabetes, these drugs are now widely used for weight loss and have become household names.

Smartphone ownership in early adolescent years is tied to risk factors for heart disease, diabetes and cancer

Semaglutide, the drug behind the blockbuster weight-loss jabs Ozempic and Wegovy, does not slow cognitive decline in people with early-stage Alzheimer’s, according to two large new studies. The results close the door, for now, on hopes that a treatment for diabetes and obesity might also help protect the brain.

People with higher fitness had greater gluteus maximus shape when compared to those with a sedentary lifestyle